⚠️ This content is not available in English.

Authors

[:fr]Anselmi G[:],
[:fr]Vaivode K[:],
[:fr]Ramos RN[:],
[:fr]Missolo-Koussou Y[:],
[:fr]Hidalgo S[:],
[:fr]Tosselo J[:],
[:fr]Nuñez N[:],
[:fr]Richer W[:],
[:fr]Vincent-Salomon A[:],
[:fr]Saxena A[:],
[:fr]Wood K[:],
[:fr]Lladser A[:],
[:fr]Piaggio E[:],
[:fr]Helft J[:],

[:fr]

Abstract

Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1c+CD163+ DCs (called DC3s) as immediate precursors of inflammatory CD88CD14+CD1c+CD163+FcεRI+ DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8+ T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8+CD103+CD69+ tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.

[:en]

Abstract

Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1cCD163 DCs (called DC3s) as immediate precursors of inflammatory CD88CD14CD1cCD163FcεRI DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8 T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8CD103CD69 tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.

[:]

Other publications

Authors :
Asselah Tarik,
Scott K Fung,
Sila Akhan,
Wan-Long Chuang,
Maria Buti,
Maurizia Brunetto,
Kosh Agarwal,
Camellia Diba,
John Jezorwski,
Véronique Berger,
Huybrecht T'jollyn,
Wen-I Tsou,
Thomas N Kakuda,
Isabelle Lonjon-Domanec,
Catherine Nalpas,
Carine Guinard-Azadian,
Thierry Verbinnen,
Erkki Lathouwers,
An De Creus,
Oliver Lenz,
Michael Biermer,
Find out more
Authors :
Alexandre Sayadi,
Claudia Campani,
Astrid Laurent-Bellue,
Marianne Ziol,
Luca Di Tommaso,
Becht Etiennet,
Benoit Terris,
Julien Calderaro,
Luca Messerini,
Miguel Albuquerque,
Federico Lipsich,
Carolina Gutierrez,
Marion Dhooge,
Lisa Lellouche,
Giuliana Amaddeo,
Alina Pascale,
Olivier Rosmorduc,
Fabio Marra,
Lorenza Rimassa,
Marco DioguardiBurgio,
Aurélie Beaufrère,
Find out more
Authors :
Julie Bex-Coudrat,
Victoria Peter,
Chaimae Saji,
Claire Dupont,
Mathilde Lavernhe,
Suoqin Jin,
Lea Chapart,
Gregory Gautier,
Olivier Thibaudeau,
Morgane Thaminy,
John Tchen,
Quentin Simon,
Xing Dai,
Kensuke Miyake,
Hajime Karasuyama,
Jean X Jiang,
Karmella Naidoo,
Marc Benhamou,
Ulrich Blank,
Renato Monteiro,
Graham Le Gros,
Agnès Coste,
Nicolas Charles,
Christophe Pellefigues,
Find out more